The North America Controlled Release Drug Delivery Market would witness market growth of 9.7% CAGR during the forecast period (2023-2030).
Controlled release drug delivery permits a large decrease in dosage frequency and dose, prevents aberrant variations in plasma drug levels, enhances efficacy, increases patient compliance, and produces a consistent pharmacological effect of the supplied drug. Controlled release drug delivery systems, in contrast to conventional ones, achieve a longer therapeutic impact by releasing the drug at the target site at a predetermined time and with known drug release kinetics. As a result of these additional advantages, the controlled release delivery system's usage is rising noticeably.
Over the course of the forecast period, it is anticipated that a shift in prescription patterns toward controlled release drug delivery over traditional systems due to advantages such as better patient compliance, high therapeutic efficacy, and lower treatment costs will aid in the market's expansion. Additionally, because of the intense competition and fragmentation of the market, pharmaceutical firms are proactive in responding to shifting consumer demands and are consistently investing in the development of these systems, which considerably increases demand.
Additionally, more than 1 in 5 people in the US are affected by a mental illness, according to the Centers for Disease Control and Prevention (CDC). Over 1 in 5 young people (ages 13 to 18) currently have, or had in the past, a mental condition that is considerably limiting. Bipolar disorder, schizophrenia, and major depression are among the serious mental diseases that affect one in every twenty-five Americans. Additionally, diabetes, cancer, and heart disease are among the chronic diseases that are the leading causes of death and disability in the US. Additionally, they play a significant role in the $4.1 trillion in annual healthcare costs for the nation.
The expanding need for controlled release medications in Canada is also a result of the rise in the prevalence of autoimmune diseases. According to Statistics Canada, 5.7 million people in Canada aged 15 or older (or 19.3%) reported having arthritis in 2017. 16.0% of males and 22.4% of women had this chronic condition, respectively. Moreover, in this region, there are numerous academic institutes and biotechnology companies working on the creation of controlled release medications. As a result, the market has attractive growth potential in the region.
The US market dominated the North America Controlled Release Drug Delivery Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $30,656.8 million by 2030. The Canada market is anticipated to grow at a CAGR of 12.2% during (2023 - 2030). Additionally, The Mexico market would register a CAGR of 11.2% during (2023 - 2030).
Based on Release Mechanism, the market is segmented into Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, Chemically Activated, Polymer Based Systems and Micro Reservoir Partition Controlled Drug Delivery Systems. Based on Technology, the market is segmented into Targeted Delivery, Coacervation, Micro Encapsulation, Transdermal, Implants, Wurster Technique and Others. Based on Application, the market is segmented into Oral Controlled-drug delivery Systems, Metered Dose Inhalers, Injectable, Transdermal & Ocular Patches and Infusion Pumps & Drug Eluting Stents. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Controlled Release Drug Delivery Market is Projected to reach USD 106.3 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Merck & Co., Inc., Alkermes PLC, Pfizer, Inc., Assertio Holdings, Inc. (Assertio Therapeutics, Inc.), Lonza Group AG (Capsugel), Colorcon, Inc. (BPSI Holdings LLC.), Corium, LLC (Gurnet Point Capital), Adare Pharma Solutions, and Coating Place, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Release Mechanism
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Chemically Activated
- Polymer Based Systems
- Micro Reservoir Partition Controlled Drug Delivery Systems
By Technology
- Targeted Delivery
- Coacervation
- Micro Encapsulation
- Transdermal
- Implants
- Wurster Technique
- Others
By Application
- Oral Controlled-drug delivery Systems
- Metered Dose Inhalers
- Injectable
- Transdermal & Ocular Patches
- Infusion Pumps & Drug Eluting Stents
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Merck & Co., Inc.
- Alkermes PLC
- Pfizer, Inc.
- Assertio Holdings, Inc. (Assertio Therapeutics, Inc.)
- Lonza Group AG (Capsugel)
- Colorcon, Inc. (BPSI Holdings LLC.)
- Corium, LLC (Gurnet Point Capital)
- Adare Pharma Solutions
- Coating Place, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Controlled Release Drug Delivery Market, by Release Mechanism
1.4.2 North America Controlled Release Drug Delivery Market, by Technology
1.4.3 North America Controlled Release Drug Delivery Market, by Application
1.4.4 North America Controlled Release Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Controlled Release Drug Delivery Market
Chapter 5. North America Controlled Release Drug Delivery Market by Release Mechanism
5.1 North America Feedback Regulated Drug Delivery Systems Market by Country
5.2 North America Activation-modulated Drug Delivery Systems Market by Country
5.3 North America Chemically Activated Market by Country
5.4 North America Polymer Based Systems Market by Country
5.5 North America Micro Reservoir Partition Controlled Drug Delivery Systems Market by Country
Chapter 6. North America Controlled Release Drug Delivery Market by Technology
6.1 North America Targeted Delivery Market by Country
6.2 North America Coacervation Market by Country
6.3 North America Micro Encapsulation Market by Country
6.4 North America Transdermal Market by Country
6.5 North America Implants Market by Country
6.6 North America Wurster Technique Market by Country
6.7 North America Others Market by Country
Chapter 7. North America Controlled Release Drug Delivery Market by Application
7.1 North America Oral Controlled-drug delivery Systems Market by Country
7.2 North America Metered Dose Inhalers Market by Country
7.3 North America Injectable Market by Country
7.4 North America Transdermal & Ocular Patches Market by Country
7.5 North America Infusion Pumps & Drug Eluting Stents Market by Country
Chapter 8. North America Controlled Release Drug Delivery Market by Country
8.1 US Controlled Release Drug Delivery Market
8.1.1 US Controlled Release Drug Delivery Market by Release Mechanism
8.1.2 US Controlled Release Drug Delivery Market by Technology
8.1.3 US Controlled Release Drug Delivery Market by Application
8.2 Canada Controlled Release Drug Delivery Market
8.2.1 Canada Controlled Release Drug Delivery Market by Release Mechanism
8.2.2 Canada Controlled Release Drug Delivery Market by Technology
8.2.3 Canada Controlled Release Drug Delivery Market by Application
8.3 Mexico Controlled Release Drug Delivery Market
8.3.1 Mexico Controlled Release Drug Delivery Market by Release Mechanism
8.3.2 Mexico Controlled Release Drug Delivery Market by Technology
8.3.3 Mexico Controlled Release Drug Delivery Market by Application
8.4 Rest of North America Controlled Release Drug Delivery Market
8.4.1 Rest of North America Controlled Release Drug Delivery Market by Release Mechanism
8.4.2 Rest of North America Controlled Release Drug Delivery Market by Technology
8.4.3 Rest of North America Controlled Release Drug Delivery Market by Application
Chapter 9. Company Profiles
9.1 Johnson & Johnson
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental & Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 Alkermes PLC
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 SWOT Analysis
9.4 Pfizer, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Geographical Expansions:
9.4.6 SWOT Analysis
9.5 Assertio Holdings, Inc. (Assertio Therapeutics, Inc.)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Acquisition and Mergers:
9.5.4 SWOT Analysis
9.6 Lonza Group Ltd. (Capsugel)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 Colorcon, Inc. (BPSI Holdings LLC.)
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Product Launches and Product Expansions:
9.7.2.2 Acquisition and Mergers:
9.7.2.3 Geographical Expansions:
9.7.3 SWOT Analysis
9.8 Corium, LLC (Gurnet Point Capital)
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.8.3 SWOT Analysis
9.9 Adare Pharma Solutions
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Acquisition and Mergers:
9.9.3 SWOT Analysis
9.10. Coating Place, Inc.
9.10.1 Company Overview
9.10.2 SWOT Analysis
TABLE 1 North America Controlled Release Drug Delivery Market, 2019 - 2022, USD Million
TABLE 2 North America Controlled Release Drug Delivery Market, 2023 - 2030, USD Million
TABLE 3 North America Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2022, USD Million
TABLE 4 North America Controlled Release Drug Delivery Market by Release Mechanism, 2023 - 2030, USD Million
TABLE 5 North America Feedback Regulated Drug Delivery Systems Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Feedback Regulated Drug Delivery Systems Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Activation-modulated Drug Delivery Systems Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Activation-modulated Drug Delivery Systems Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Chemically Activated Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Chemically Activated Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Polymer Based Systems Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Polymer Based Systems Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Micro Reservoir Partition Controlled Drug Delivery Systems Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Micro Reservoir Partition Controlled Drug Delivery Systems Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Controlled Release Drug Delivery Market by Technology, 2019 - 2022, USD Million
TABLE 16 North America Controlled Release Drug Delivery Market by Technology, 2023 - 2030, USD Million
TABLE 17 North America Targeted Delivery Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Targeted Delivery Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Coacervation Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Coacervation Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Micro Encapsulation Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Micro Encapsulation Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Transdermal Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Transdermal Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Implants Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Implants Market by Country, 2023 - 2030, USD Million
TABLE 27 North America Wurster Technique Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Wurster Technique Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Controlled Release Drug Delivery Market by Application, 2019 - 2022, USD Million
TABLE 32 North America Controlled Release Drug Delivery Market by Application, 2023 - 2030, USD Million
TABLE 33 North America Oral Controlled-drug delivery Systems Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Oral Controlled-drug delivery Systems Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Metered Dose Inhalers Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Metered Dose Inhalers Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Injectable Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Injectable Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Transdermal & Ocular Patches Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Transdermal & Ocular Patches Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Infusion Pumps & Drug Eluting Stents Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Infusion Pumps & Drug Eluting Stents Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Controlled Release Drug Delivery Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Controlled Release Drug Delivery Market by Country, 2023 - 2030, USD Million
TABLE 45 US Controlled Release Drug Delivery Market, 2019 - 2022, USD Million
TABLE 46 US Controlled Release Drug Delivery Market, 2023 - 2030, USD Million
TABLE 47 US Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2022, USD Million
TABLE 48 US Controlled Release Drug Delivery Market by Release Mechanism, 2023 - 2030, USD Million
TABLE 49 US Controlled Release Drug Delivery Market by Technology, 2019 - 2022, USD Million
TABLE 50 US Controlled Release Drug Delivery Market by Technology, 2023 - 2030, USD Million
TABLE 51 US Controlled Release Drug Delivery Market by Application, 2019 - 2022, USD Million
TABLE 52 US Controlled Release Drug Delivery Market by Application, 2023 - 2030, USD Million
TABLE 53 Canada Controlled Release Drug Delivery Market, 2019 - 2022, USD Million
TABLE 54 Canada Controlled Release Drug Delivery Market, 2023 - 2030, USD Million
TABLE 55 Canada Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2022, USD Million
TABLE 56 Canada Controlled Release Drug Delivery Market by Release Mechanism, 2023 - 2030, USD Million
TABLE 57 Canada Controlled Release Drug Delivery Market by Technology, 2019 - 2022, USD Million
TABLE 58 Canada Controlled Release Drug Delivery Market by Technology, 2023 - 2030, USD Million
TABLE 59 Canada Controlled Release Drug Delivery Market by Application, 2019 - 2022, USD Million
TABLE 60 Canada Controlled Release Drug Delivery Market by Application, 2023 - 2030, USD Million
TABLE 61 Mexico Controlled Release Drug Delivery Market, 2019 - 2022, USD Million
TABLE 62 Mexico Controlled Release Drug Delivery Market, 2023 - 2030, USD Million
TABLE 63 Mexico Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2022, USD Million
TABLE 64 Mexico Controlled Release Drug Delivery Market by Release Mechanism, 2023 - 2030, USD Million
TABLE 65 Mexico Controlled Release Drug Delivery Market by Technology, 2019 - 2022, USD Million
TABLE 66 Mexico Controlled Release Drug Delivery Market by Technology, 2023 - 2030, USD Million
TABLE 67 Mexico Controlled Release Drug Delivery Market by Application, 2019 - 2022, USD Million
TABLE 68 Mexico Controlled Release Drug Delivery Market by Application, 2023 - 2030, USD Million
TABLE 69 Rest of North America Controlled Release Drug Delivery Market, 2019 - 2022, USD Million
TABLE 70 Rest of North America Controlled Release Drug Delivery Market, 2023 - 2030, USD Million
TABLE 71 Rest of North America Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2022, USD Million
TABLE 72 Rest of North America Controlled Release Drug Delivery Market by Release Mechanism, 2023 - 2030, USD Million
TABLE 73 Rest of North America Controlled Release Drug Delivery Market by Technology, 2019 - 2022, USD Million
TABLE 74 Rest of North America Controlled Release Drug Delivery Market by Technology, 2023 - 2030, USD Million
TABLE 75 Rest of North America Controlled Release Drug Delivery Market by Application, 2019 - 2022, USD Million
TABLE 76 Rest of North America Controlled Release Drug Delivery Market by Application, 2023 - 2030, USD Million
TABLE 77 Key Information – Johnson & Johnson
TABLE 78 KEY INFORMATION - Merck & Co., Inc.
TABLE 79 Key Information – Alkermes PLC
TABLE 80 Key Information – Pfizer, Inc.
TABLE 81 Key Information – Assertio Holdings, Inc.
TABLE 82 Key Information –Lonza Group Ltd.
TABLE 83 Key Information – Colorcon, Inc.
TABLE 84 Key Information – Corium, LLC
TABLE 85 Key Information – Adare Pharma Solutions
TABLE 86 Key Information – Coating Place, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Controlled Release Drug Delivery Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Controlled Release Drug Delivery Market
FIG 4 Porter’s Five Forces Analysis – Controlled Release Drug Delivery Market
FIG 5 North America Controlled Release Drug Delivery Market share by Release Mechanism, 2022
FIG 6 North America Controlled Release Drug Delivery Market share by Release Mechanism, 2030
FIG 7 North America Controlled Release Drug Delivery Market by Release Mechanism, 2019 - 2030, USD Million
FIG 8 North America Controlled Release Drug Delivery Market share by Technology, 2022
FIG 9 North America Controlled Release Drug Delivery Market share by Technology, 2030
FIG 10 North America Controlled Release Drug Delivery Market by Technology, 2019 - 2030, USD Million
FIG 11 North America Controlled Release Drug Delivery Market share by Application, 2022
FIG 12 North America Controlled Release Drug Delivery Market share by Application, 2030
FIG 13 North America Controlled Release Drug Delivery Market by Application, 2019 - 2030, USD Million
FIG 14 North America Controlled Release Drug Delivery Market share by Country, 2022
FIG 15 North America Controlled Release Drug Delivery Market share by Country, 2030
FIG 16 North America Controlled Release Drug Delivery Market by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Johnson & Johnson
FIG 18 Swot Analysis: Johnson & Johnson
FIG 19 Recent strategies and developments: Merck and Co., Inc.
FIG 20 Swot Analysis: Merck & Co., Inc.
FIG 21 Swot Analysis: Alkermes PLC
FIG 22 Swot Analysis: Pfizer, Inc.
FIG 23 Swot Analysis: Assertio Holdings, Inc.
FIG 24 Swot Analysis: Lonza Group AG
FIG 25 Recent strategies and developments: Colorcon, Inc.
FIG 26 Swot Analysis: Colorcon, Inc.
FIG 27 Swot Analysis: Corium, LLC
FIG 28 Swot Analysis: Adare Pharma Solutions
FIG 29 Swot Analysis: Coating Place, Inc.